Meghan Miller, Erica D. Musser, Gregory S. Young, Brent
Olson, Robert D. Steiner, Joel T. Nigg. Sibling Recurrence Risk and
Cross-aggregation of Attention-Deficit/Hyperactivity Disorder and Autism
Spectrum Disorder. JAMA Pediatr.
Published online December 10, 2018. doi:10.1001/jamapediatrics.2018.4076
Key Points
Question What are the
rates of within-diagnosis sibling recurrence and sibling cross-aggregation of
attention-deficit/hyperactivity disorder and autism spectrum disorder among
later-born siblings of diagnosed children?
Findings In this
population-based study of 15 175 US children, compared with later-born siblings
of nondiagnosed children, later-born siblings of those with autism spectrum
disorder were more likely to be diagnosed with autism spectrum disorder or
attention-deficit/hyperactivity disorder. In addition, compared with later-born
siblings of nondiagnosed children, later-born siblings of children with
attention-deficit/hyperactivity disorder were more likely to be diagnosed with
attention-deficit/hyperactivity disorder or autism spectrum disorder.
Meaning Later-born
siblings of children with autism spectrum disorder appear to be at elevated
risk of attention-deficit/hyperactivity disorder and vice versa with
implications for etiologic overlap and clinical monitoring.
Abstract
Importance
Attention-deficit/hyperactivity disorder (ADHD) and autism spectrum
disorder (ASD) are believed to partially share genetic factors and biological
influences. As the number of children with these diagnoses rises, so does the
number of younger siblings at presumed risk for ADHD and ASD; reliable
recurrence risk estimates within and across diagnoses may aid screening and
early detection efforts and enhance understanding of potential shared causes.
Objective To examine
within-diagnosis sibling recurrence risk and sibling cross-aggregation of ADHD
and ASD among later-born siblings of children with either disorder.
Design, Setting, and Participants Using data extracted from medical records of
2 large health care systems in the United States, estimates of recurrence risk
and cross-aggregation in later-born siblings of children with ADHD or ASD were
compared with later-born siblings of children without these diagnoses. One data
set included children seen between January 1, 1995, and December 31, 2013; the
other included children born between January 1, 1998, and May 17, 2010.
Participants included 15 175 later-born siblings of children with ADHD, ASD,
and no known diagnosis. The study was conducted from October 2, 2017, to August
14, 2018.
Main Outcomes and Measures
Diagnoses of ASD or ADHD in the later-born sibling, ascertained from
medical records, were the primary outcomes of interest; moderators included
sex, gestational age, and maternal age.
Results A total of
15 175 later-born siblings were classified by familial risk status based on the
older child’s diagnostic status: ADHD risk (n = 730; male [51.92%]), ASD risk
(n = 158; male [48.10%]), and no known risk (n = 14 287; male [50.73%]).
Compared with later-born siblings of children without ADHD or ASD, later-born
siblings of children with ASD were more likely to be diagnosed with ASD (odds
ratio [OR], 30.38; 95% CI, 17.73-52.06) or ADHD in the absence of ASD (OR,
3.70; 95% CI, 1.67-8.21). Compared with later-born siblings of children without
a diagnosis, later-born siblings of children with ADHD were more likely to be
diagnosed with ADHD (OR, 13.05; 95% CI, 9.86-17.27) or ASD in the absence of
ADHD (OR, 4.35; 95% CI, 2.43-7.79).
Conclusions and Relevance
Later-born siblings of children with ASD or ADHD appear to be at
elevated risk for the same disorder, but also of being diagnosed with the other
disorder. These findings provide further support for shared familial mechanisms
underlying ASD and ADHD, which may be useful for genetic and prospective
developmental studies. Later-born siblings of children with ADHD or ASD should
be monitored for both conditions.
_______________________________________________________________________
"These findings provide further support for shared
familial mechanisms underlying ASD and ADHD, which may be useful for genetic
and prospective developmental studies," write Meghan Miller, PhD, from the
University of California, Davis, Health System, Sacramento, and colleagues…
The researchers acknowledge study limitations, including the
lack of information on parental psychopathology, comorbidities, or birth complications,
that could have affected outcomes.
"Etiologically, our findings of sibling
cross-aggregation are consistent with partially shared genetic mechanisms
underlying ASD and ADHD," write Miller and colleagues.
"Practitioners may wish to share such information with
families given the potential relevance of monitoring social communication,
attention, and behavior regulation skills in later-born siblings of children
with ASD or ADHD," they conclude.
In an accompanying editorial, Tony Charman, PhD, and Emily
J. H. Jones, PhD, from King's College London and the University of London,
United Kingdom, write: "These within- and cross-condition recurrence
figures are of important clinical usefulness in terms of informing discussions
with parents about the need for enhanced developmental surveillance for
neurodevelopmental conditions, such as ASD and ADHD, in their younger
children."
Charman and Jones note, however, that the small sample size
and wide confidence intervals may limit the clinical utility of the data and
suggest that caution be used when conveying this information to parents.
"Although studies such as the present one will help to
provide accessible and clinically translatable estimates of recurrence, more
specialist training or even specialist genetic counseling services might have
to be developed to provide this information to families sensitively and clearly
in the way that is increasingly the case for monogenic forms of
neurodevelopmental conditions," conclude the editorialists.
https://www.medscape.com/viewarticle/906333
No comments:
Post a Comment